MeSH tree: C04.557.470.670
Researchers from the Terasaki Institute for Biomedical Innovation, together with key pioneers in glioma biology, neuro-oncology and stem cell biology, have published a comprehensive review in Society for Neuro-Oncology's ...
Jun 15, 2026
0
3
Dual-target CAR T-cell therapy for recurrent glioblastoma (GBM), delivered directly into the cerebrospinal fluid (CSF), triggers a broad immune response, with natural killer (NK) cell activation linked to better patient outcomes ...
Jun 15, 2026
0
3
An international study led by a scientist at the University of Ottawa Faculty of Medicine is opening new frontiers in the fight against glioblastoma (GB), a devastating cancer behind the most malignant and treatment-resistant ...
Jun 14, 2026
0
13
For patients diagnosed with IDH-mutant glioma, an incurable brain tumor that often affects adults in their 30s and 40s, treatment typically works at first. However, the cancer almost always returns, and when it does, it frequently ...
Jun 9, 2026
0
10
A team of experimental oncology researchers at the University of Alberta is shedding light on how the deadly brain cancer glioblastoma spreads. In newly published research, they identify a potential treatment target to slow ...
Jun 6, 2026
0
14
A drug widely used to combat intestinal worms has shown promise in treating brain tumors, with scientists calling for more trials to confirm it works in humans. A systematic review published in the British Journal of Clinical ...
Jun 5, 2026
0
7
Researchers at the Institute of Environmental Medicine (IMM), Karolinska Institutet, have identified a possible mechanism behind the spread of the aggressive brain tumor diffuse midline glioma. The study shows that the brain's ...
Jun 1, 2026
0
4
For most children diagnosed with medulloblastoma, the most common malignant pediatric brain tumor, survival rates are encouraging. But for a subset, remission is not the end of the story. Roughly 30% of patients will see ...
May 26, 2026
0
11
Glioblastoma is one of the most treatment-resistant brain tumors, making it especially difficult to treat. Part of that resistance stems from its unique tumor microenvironment—the complex mix of cells and biological activity ...
May 22, 2026
0
9
Scientists at the UCLA Health Jonsson Comprehensive Cancer Center have developed a new cytokine-armored CAR-T cell therapy that helps the immune system better attack aggressive brain tumors in mice while reducing dangerous ...
May 20, 2026
0
10
